Embed Size (px)
DESCRIPTION
Hepatitis C among people who inject drugs in Indonesia : An urgent public health crisis. Edo Agustian Indonesian Drug Users Network [email protected] HCV and PWID in Asia Strategies for Treatment Scale up. Outline of Presentation. - PowerPoint PPT Presentation
Citation preview
www.aids2014.org
• Edo Agustian• Indonesian Drug Users Network• [email protected]
• HCV and PWID in Asia Strategies for Treatment Scale up
Hepatitis C among people who inject drugs in Indonesia : An urgent public
health crisis
www.aids2014.org
Outline of Presentation
• Overview of hepatitis C among people who inject drugs in Indonesia
• Indonesia’s national response
• Barriers to testing and treatment access
• Advocacy and community engagement
www.aids2014.org
Viral Hepatitis in Indonesia
www.aids2014.org
The national response to the prevention, treatment and management of
hepatitis C among people who inject drugs
• Late response, fragmented• Indonesia does not conduct routine national surveillance • There is no national clinical guideline for diagnosis,
treatment and care for HCV• The Ministry of Health first established a national
program focused on viral hepatitis in 2011, under the Sub Directorate for Gastrointestinal Infections and Diarrheal Diseases.
www.aids2014.org
www.aids2014.org
Monitoring of the quality of harm reduction programs in 9 provinces by the drug user community
www.aids2014.org
www.aids2014.org
www.aids2014.org
www.aids2014.org
Advocacy and community engagementSince 2011, PKNI has worked with drug users, policy-makers, and service providers to raise awareness about Hep C and ensure that the community is meaningfully involved in the national response. Highlights include:
o Fill pre grant opposition against Sofosbufir patent registrationo Training of service providers across 9 provinceso Collaboration with Indonesian Liver Researchers Association
and Ministry of health on public Hep C campaigno Policy briefing on Hep Co Hepatitis C Community Task Force to input in MoH planningo Treatment price reductions and pharma advocacyo Involved in developing National Guideline for Hep C Care,
Support and Treatment with MoH in 2014
www.aids2014.org
www.aids2014.org
www.aids2014.org
